5 completed. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
Follow Neoplasm: new trials by email Literature Review of Neoplasm trials Research Report on Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban rivaroxaban, Low-molecular-weight heparin - Neoplasm, Venous Thromboembolism | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 159 | 2016-09-01 | 2018-08-13 |
| Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide Polihexanide 2%, Metronidazole 0.8% - Neoplasm, Wounds and Injuries | Phase 3 | Completed | University of Sao Paulo | 24 | 2013-09-01 | 2015-09-02 |
| Iressa Expanded Access Program (EAP) ZD1839 (Gefitinib) - Carcinoma, Non-small-cell Lung | Phase 3 | Completed | AstraZeneca | 2000-08-01 | 2013-01-04 | |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy Epoetin alfa - Anemia, Cancer | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 375 | 1996-08-01 | 2011-05-18 |
| The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy epoetin alfa - Anemia, Multiple Myeloma | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 201 | 1995-02-01 | 2011-05-18 |
Neoplasms (5) · Anemia (2) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Lymphoma (1) · Multiple Myeloma (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Small Cell Lung Carcinoma (1) · Venous Thromboembolism (1) · Wounds and Injuries (1)
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Cardiovascular Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Vascular Diseases (2) · Adnexal Diseases (1) · Blood Protein Disorders (1)
Epoetin Alfa (2) · Dalteparin (1) · Gefitinib (1) · Heparin, Low-Molecular-Weight (1) · Rivaroxaban (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · University of Sao Paulo (1)
Brazil (1) · France (1) · United States (1)
Guy Meyer, MD (1)